# Jesús Egido

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jesus-egido/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,762 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 108 |
| i10-index | 533 |
| Last Known Institution | Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas |
| OpenAlex ID | https://openalex.org/A5108079533 |
| Works | 808 |

## Researcher papers

- [Inflammation and angiotensin II](https://scholariq.org/papers/inflammation-and-angiotensin-ii/)
- [Role of the Renin-Angiotensin System in Vascular Diseases](https://scholariq.org/papers/role-of-the-renin-angiotensin-system-in-vascular-diseases/)
- [The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy](https://scholariq.org/papers/the-starmen-trial-indicates-that-alternating-treatment-with-corticosteroids-and/)
- [Implementation of proteomic biomarkers: making it work](https://scholariq.org/papers/implementation-of-proteomic-biomarkers-making-it-work/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [NF-κB Signaling Pathways](https://scholariq.org/topics/nf-b-signaling-pathways/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)

## Researcher university

- [Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas](https://scholariq.org/institutions/centro-de-investigacion-biomedica-en-red-diabetes-y-enfermedades-metabolicas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.